How frequently do you recommend ordering labs to monitor for side effects of disease-modifying therapies for multiple sclerosis?  

Yes, the monitoring depends on which DMT the patient is on. For patients on B-cell-depleting therapies, I screen for Hep B and latent TB prior to therapy and check a CBC and CMP every 6 months, with yearly immunoglobulin monitoring. For JCV Ab-negative patients on Tysabri, I check a CBC, CMP, and ...